| REVIEW ARTICLE |
|
| Year : 2015 | Volume
: 4
| Issue : 1 | Page : 5-15 |
|
|
Novel treatment strategies for intervertebral disc degeneration
Moattar Raza Rizvi
Department of Nursing, College of Applied Medical Sciences, Majmaah University, Majmaah, Saudi Arabia
Correspondence Address:
Moattar Raza Rizvi
Department of Nursing, College of Applied Medical Sciences, Majmaah University, Majmaah
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2278-0521.151403
|
|
|
Intervertebral disc degenerative (IVDD) is a common orthopaedic condition characterized by a series of cellular, biochemical, structural and functional changes that imparts a large socioeconomic impact on healthcare system. Progressive loss of normal extracellular matrix constituents, namely proteoglycans and water content, is thought to be a key contributor to IVDD. The ability to sustain or augment normal matrix composition may slow down or reverse disc degeneration. Traditional concepts for treatment of lumbar disc degeneration have aimed at symptomatic relief by limiting motion in the lumbar spine, but novel treatment strategies involving direct injection of active substance, stem cells, growth factors and gene therapy have been attracting more attention in respect to prevent, slow or even reverse disc degeneration. Understanding the pathophysiological basis of disc degeneration will lay the foundation for the emergence of exciting new regenerative or reparative biological treatments for this debilitating condition either by inducing disc regeneration or replacing the degenerated disc. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
